The 2D Experimental Pilot Line (2D-EPL), a project grown from the Graphene Flagship, has launched its first customisable wafer run targeting sensor applications. Companies, universities and research institutes can include their designs as dies on joint wafers, to test their ideas for devices on a larger scale at relatively low costs.
Graphene Flagship researchers have developed an innovative graphene sensor to capture the sound of a single bacterium. These graphene-enabled sensors tell apart living organisms, which enables researchers to identify drug-resistant bacteria through the detection of distinctive sounds.
Graphene Flagship researchers are using graphene to develop the ultimate pressure sensor for presence detection.
Graphene Flagship partners use graphene to develop fully flexible NFC devices for home automation applications, including electronic keys.
Graphene is making great strides in smart footwear. Graphene Flagship partners have developed 3D printed insoles with embedded graphene sensors to monitor and enhance an athlete’s performance.
Graphene Flagship Partner ICN2, Catalan Institute of Nanoscience and Nanotechnology, have created graphene-based electroluminescent inks that work as effective gas detectors, paving the way for real-monitoring and greater air pollution awareness.
Graphene Flagship Associated Member Atomic Mechanics, have applied their expertise with graphene-enabled flexible sensors to enhance interactions with any surface, which could find different applications in robotic surgery.
Ultra-small devices show nano-synaptic responses with low power consumption.
Graphene Flagship Associated Member Grapheal showcases their awarded graphene-enabled products at CES 2022 tradeshow in Las Vegas.
Introducing the Graphene Flagship’s new manufacturing facility for graphene-based electronics, optoelectronics and sensors
New technologies for the production of layered materials can help us manufacture low cost, chip-scale gas sensors for the Internet of Things (IoT).
Leading pharmaceutical company Merck will collaborate with INBRAIN to develop smart neuromodulation for targeted treatment of chronic diseases.
The new company will market graphene-enabled image sensors with disruptive cost and performance potential compared to current alternatives.
Chip based on layered materials serves as both an image sensor and a neural network, classifying images a thousand times faster than conventional machine-vision systems